Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other ORP type
Data sources: ZENODO
Zenodo
Claim

How does the use of SGLT2 inhibitors impact long-term kidney function in living kidney donors without pre-existing proteinuria?

descriptionPublicationkeyboard_double_arrow_right Other ORP type Under curationPublisher:Zenodo
Authors: Tripdatabase;

doi: 10.5281/zenodo.20506664

How does the use of SGLT2 inhibitors impact long-term kidney function in living kidney donors without pre-existing proteinuria?

Abstract

SGLT2 inhibitors are linked with renal protection in diverse populations, yet their impact on long-term kidney function in healthy kidney donors remains unexplored, necessitating further research.

Powered by OpenAIRE graph
Found an issue? Give us feedback